CD16(+)NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice

por Williams, Brent A., Wang, Xing-Hua, Leyton, Jeffrey V., Maghera, Sonam, Deif, Bishoy, Reilly, Raymond M., Minden, Mark D., Keating, Armand
Publicado 2018